Cleveland Clinic Rheumatology and Immunology Series
Cleveland Clinic 2020 ACR Update on GCA: Is Tocilizumab + Ultra-Short Glucocorticoid Administration Effective for Newly Diagnosed Disease? Does Mavrilimumab Reduce Risk of Flare and Increase Sustained Remission?
Login to view comments.
Click here to Login
Videos